prikaz prve stranice dokumenta Dobrobiti i rizici primjene oralne hormonske kontracepcije
  Download
PDF 708.9 KB
master's thesis
Dobrobiti i rizici primjene oralne hormonske kontracepcije
Zagreb: University of Zagreb, School of Medicine, 2016. urn:nbn:hr:105:195661
Mandić, Eva
University of Zagreb
School of Medicine
Department of Gynecology and Obstetrics

Institutional repository: Dr Med - University of Zagreb School of Medicine Digital Repository

Cite this document

Mandić, E. (2016). Dobrobiti i rizici primjene oralne hormonske kontracepcije (Master's thesis). Zagreb: University of Zagreb, School of Medicine. Retrieved from https://urn.nsk.hr/urn:nbn:hr:105:195661

Mandić, Eva. "Dobrobiti i rizici primjene oralne hormonske kontracepcije." Master's thesis, University of Zagreb, School of Medicine, 2016. https://urn.nsk.hr/urn:nbn:hr:105:195661

Mandić, Eva. "Dobrobiti i rizici primjene oralne hormonske kontracepcije." Master's thesis, University of Zagreb, School of Medicine, 2016. https://urn.nsk.hr/urn:nbn:hr:105:195661

Mandić, E. (2016). 'Dobrobiti i rizici primjene oralne hormonske kontracepcije', Master's thesis, University of Zagreb, School of Medicine, accessed 26 November 2024, https://urn.nsk.hr/urn:nbn:hr:105:195661

Mandić E. Dobrobiti i rizici primjene oralne hormonske kontracepcije [Master's thesis]. Zagreb: University of Zagreb, School of Medicine; 2016 [cited 2024 November 26] Available at: https://urn.nsk.hr/urn:nbn:hr:105:195661

E. Mandić, "Dobrobiti i rizici primjene oralne hormonske kontracepcije", Master's thesis, University of Zagreb, School of Medicine, Zagreb, 2016. Available at: https://urn.nsk.hr/urn:nbn:hr:105:195661

Metadata
TitleDobrobiti i rizici primjene oralne hormonske kontracepcije
Title (english)Benefits and risks of oral hormonal contraception
AuthorEva Mandić
MentorMarina Šprem Goldštajn (mentor)
Committee memberMiro Kasum (predsjednik povjerenstva)
Committee memberDinka Pavičić-Baldani (član povjerenstva)
Committee memberMarina Šprem Goldštajn (član povjerenstva)
GranterUniversity of Zagreb
School of Medicine
(Department of Gynecology and Obstetrics)
Zagreb
Defense date and country2016-07-15, Croatia
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Gynecology and Obstetrics
Abstract
Oralna hormonska kontracepcija (OHK) više je od 50 godina u upotrebi i danas se smatra najpouzdanijom reverzibilnom kontracepcijskom metodom. Osigurava učinkovitu zaštitu od trudnoće te svojim kontracepcijskim djelovanjem zauzima centralnu ulogu u kontroli plodnosti i planiranju obitelji. Visoka učinkovitost, jednostavnost primjene, reverzibilno djelovanje i financijska prihvatljivost čine OHK rješenjem prvog izbora za niz rizičnih čimbenika koji ugrožavaju zdravlje žena i djece diljem svijeta. Nekontracepcijske dobrobiti OHK doprinose očuvanju reproduktivnog zdravlja žene. Izgleda da OHK smanjuje incidenciju raka ovarija, endometrija i debelog crijeva. Također reducira incidenciju izvanmaterničnih trudnoća, funkcionalnih cista jajnika, zdjelične upalne bolesti, benignih bolesti dojke te osteoporoze. Terapijski učinci OHK očituju se u regulaciji menstruacijskog ciklusa te povoljnim učincima na endometriozu, miome, hiperandrogenizam i sindrom policističnih jajnika. Smatra se da oko 20% korisnica koristi OHK primarno kao terapijsku opciju, ali korištenje oralne kontracepcije kao lijeka često je usporedno s kontracepcijskim potrebama. Danas su dobro znani i opisani rizici i neželjeni učinci korištenja OHK. Česte nuspojave su obično samolimitirajuće i nestaju unutar tri mjeseca. Za kliničku praksu su najvažniji kardiovaskularni i neoplastični rizici. Kardiovaskularni se rizici manifestiraju kroz povećanu incidenciju arterijskih i venskih tromboza. Neka istraživanja upućuju na povećani rizik za obolijevanje od raka dojke i raka cerviksa pri korištenju OHK, međutim rezultati su kontradiktorni te to područje treba bolje istražiti. Ipak, čini se da dobrobiti primjene OHK daleko nadmašuju rizike. Štoviše, postoje naznake da OHK može blago utjecati na produljenje životnog vijeka.
Abstract (english)
Oral hormonal contraception (OHC) has been in use for over 50 years and today it is considered the most reliable reversible contraceptive method. It ensures efficient pregnancy protection and its contraceptive effects have the central role in fertility control and family planning. High efficiency, simple use, reversible activity and financial acceptance make OHC the first choice solution for multiple factors which are endangering the health of women and children worldwide. Non-contraceptive benefits of OHC contribute to preservation of women's reproductive health. It seems that OHC reduces incidence of ovarian, endometrial and colorectal cancer. Also, it reduces incidence of ectopic pregnancies, functional ovarian cysts, pelvic inflammatory disease, benign breast diseases and osteoporosis. Therapeutic effects of OHC are regulation of menstrual cycle, endometriosis , myomas, hyperandrogenism and polycystic ovary syndrome. Approximately 20% of users are considered to use OHC primarily as therapeutic option, but using OHC as medical tretment often comes along with contraceptive needs. Risks and side effects of OHC are well known nowadays. Common side effects are usually self-limiting and last no longer than three months. The most important risks in clinical practice are cardiovascular and neoplastic. Cardiovascular risks are manifested through increased risk of arterial and venous thrombosis. Some studies indicate that using OHC increases the risk of breast and cervical cancer, but the results are contradictory and that topic requires further research. However, it seems that benefits of using OHC outweight risks by far. Furthermore, there are indications that OHC could slightly increase life expectancy.
Keywords
Keywords (english)
Languagecroatian
URN:NBNurn:nbn:hr:105:195661
Study programmeTitle: Medicine
Study programme type: university
Study level: integrated undergraduate and graduate
Academic / professional title: doktor/doktorica medicine (doktor/doktorica medicine)
Type of resourceText
File originBorn digital
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2017-08-18 08:55:59